Tag: entrepreneurs
-
Diabetes Biotech Acquires GSK Spin-Off
24 September 2015. Intarcia Therapeutics, a developer of long-acting treatments for diabetes, is purchasing Phoundry Pharmaceuticals, a discoverer of engineered peptides for metabolic and other disorders. Phoundry — a spin-off company from GlaxoSmithKline in Research Triangle Park, North Carolina — is being acquired by Intarcia for an undisclosed amount of cash and stock. Intarcia, based…
-
Clinical Trial Underway Testing Cancer Surgery Aid
22 September 2015. A clinical trial is enrolling patients with soft tissue sarcoma to test a synthetic peptide that illuminates cancer cells to make them more easily removed during surgery. The early-stage study is testing the safety of the peptide made by Blaze Bioscience Inc. in Seattle and conducted at Cedars-Sinai Medical Center in Los…
-
Virus Particles Rebuilt to Boost Immunotherapies
22 September 2015. Engineers at Stanford University redesigned a hepatitis virus from the inside out to make it a better vehicle to stimulate the immune system for treating disease. The team led by chemical and bioengineering professor James Swartz published its results yesterday in Proceedings of the National Academy of Sciences (paid subscription required). Swartz…
-
Optical Device IDs Healthy, Cancerous Tissue in Surgery
18 September 2015. An engineering and medical team at University of Illinois in Champaign designed a surgical tool that identifies and discriminates between healthy and cancerous tissue in real time when removing tumors. Researchers led by engineering professor Stephen Boppart published results of a study testing the hand-held device with 35 breast cancer patients earlier…
-
Allied Minds Forming Space Signaling Company
17 September 2015. Allied Minds, a research commercialization company in Boston, is forming a new enterprise harnessing space satellites to detect wireless signals from earth for maritime, emergency, and commercial applications. The company, HawkEye 360 Inc., is licensing research on radio-frequency communications from Virginia Polytechnic Institute and State University, designed initially for U.S. defense and…
-
Spin-Off Formed to Develop Brain Disorder Therapies
16 September 2015. A new enterprise developing biologic therapies for disorders of the brain and nervous system is underway, spun-off from the acquisition in July 2015 of Naurex Inc. by the pharmaceutical company Allergan plc. The new company, Aptinyx Inc. in Evanston, Illinois will have many of the same team at Naurex, itself a spin-off enterprise from Northwestern…
-
NIH Backing Alzheimer’s Onset Drug Trial
15 September 2015. National Institute on Aging, part of National Institutes of Health, is funding a late-stage clinical trial testing a current epilepsy drug as a treatment to delay the early onset of Alzheimer’s symptoms. The $7.5 million grant, part of NIH’s national plan to address Alzheimer’s disease, supports the trial testing a low-dose formulation…
-
Simple Scaffold Developed for Synthetic Heart Tissue
28 August 2015. Engineers at University of Toronto in Canada designed a biocompatible mesh framework that makes it easier to grow synthetic heart muscle tissue for research and medical use. The team led by chemical engineering professor Milica Radisic published its findings today in the journal Science Advances. Radisic and first author Boyang Zhang are…
-
Allied-Bristol Licensing Immunotherapy Technology
27 August 2015. Allied-Bristol Life Sciences, a joint venture of science commercialization company Allied Minds and Bristol-Myers Squibb, is licensing a new type of synthetic chemistry technology from Yale University that can stimulate the immune system to treat cancer. Financial details of the licensing agreement were not disclosed. The agreement covers a technology known as…
-
All-Purpose Hand-Held Device Checks for Vital Signs
24 August 2015. Biomedical engineers at Johns Hopkins University in Baltimore developed a portable device that quickly returns a person’s vital health indicators in an ambulance, at an outpatient clinic, or even at home. Test results of the device, called MouthLab, led by biomedical engineering and of otolaryngology professor Gene Fridman, appear in the September…